DK0953576T3 - Aktivt hedgehog-proteinkonjugat, fremgangsmåde til fremstilling heraf og anvendelse - Google Patents

Aktivt hedgehog-proteinkonjugat, fremgangsmåde til fremstilling heraf og anvendelse

Info

Publication number
DK0953576T3
DK0953576T3 DK99108032T DK99108032T DK0953576T3 DK 0953576 T3 DK0953576 T3 DK 0953576T3 DK 99108032 T DK99108032 T DK 99108032T DK 99108032 T DK99108032 T DK 99108032T DK 0953576 T3 DK0953576 T3 DK 0953576T3
Authority
DK
Denmark
Prior art keywords
hedgehog protein
preparation
hydrophobic
protein conjugate
amino acids
Prior art date
Application number
DK99108032T
Other languages
English (en)
Inventor
Angelika Esswein
Kurt Lang
Petra Rueger
Tilmann Seytter
Original Assignee
Curis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP98107911A external-priority patent/EP0953575A1/de
Application filed by Curis Inc filed Critical Curis Inc
Application granted granted Critical
Publication of DK0953576T3 publication Critical patent/DK0953576T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK99108032T 1998-04-30 1999-04-23 Aktivt hedgehog-proteinkonjugat, fremgangsmåde til fremstilling heraf og anvendelse DK0953576T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98107911A EP0953575A1 (de) 1998-04-30 1998-04-30 Aktives Hedgehog-Protein-Konjugat, Verfahren zur Herstellung und Verwendung
EP98116733 1998-09-03

Publications (1)

Publication Number Publication Date
DK0953576T3 true DK0953576T3 (da) 2006-03-20

Family

ID=26149214

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99108032T DK0953576T3 (da) 1998-04-30 1999-04-23 Aktivt hedgehog-proteinkonjugat, fremgangsmåde til fremstilling heraf og anvendelse

Country Status (18)

Country Link
US (4) US6468978B1 (da)
EP (2) EP0953576B1 (da)
JP (1) JP3433136B2 (da)
KR (1) KR19990083621A (da)
CN (1) CN1233616A (da)
AT (1) ATE308563T1 (da)
AU (1) AU719797B2 (da)
CA (1) CA2269221A1 (da)
CY (1) CY1105683T1 (da)
DE (1) DE69928040T2 (da)
DK (1) DK0953576T3 (da)
ES (1) ES2252886T3 (da)
HU (1) HUP9901411A2 (da)
IL (1) IL129620A (da)
MA (1) MA26625A1 (da)
NO (1) NO992090L (da)
NZ (1) NZ335385A (da)
SG (1) SG80028A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1034269A1 (en) * 1997-11-28 2000-09-13 Roche Diagnostics GmbH An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes
US6897297B1 (en) * 1997-12-03 2005-05-24 Curis, Inc. Hydrophobically-modified protein compositions and methods
DE69928040T2 (de) * 1998-04-30 2006-07-27 Curis, Inc., Cambridge Aktives Hedgehog-Protein-Konjugat, Verfahren zur Herstellung und Verwendung
ES2253851T3 (es) * 1998-08-07 2006-06-01 Curis, Inc. Composicion farmaceutica estable de proteinas hedgehog y uso de la misma.
TW570805B (en) * 1998-09-01 2004-01-11 Hoffmann La Roche Water-soluble pharmaceutical composition in an ionic complex
WO2000035948A1 (en) * 1998-12-03 2000-06-22 Biogen, Inc. Methods and compositions for treating disorders involving excitotoxicity
EP1025861A1 (de) * 1999-02-04 2000-08-09 Roche Diagnostics GmbH Pharmazeutische Zusammensetzung von hydrophob modifizierten Hedgehog-Proteinen und deren Verwendung
AU782493B2 (en) * 1999-06-01 2005-08-04 Curis, Inc. Polymer conjugates of hedgehog proteins and uses
US7052514B2 (en) * 2000-04-28 2006-05-30 Curis, Inc. Methods and reagents for tissue engineering of cartilage in vitro
US7573637B2 (en) * 2004-08-03 2009-08-11 Seiko Epson Corporation Intrinsic polarizer and method of manufacturing an intrinsic polarizer
US8669418B2 (en) * 2005-12-22 2014-03-11 Vib Vzw Means and methods for mediating protein interference
WO2009108868A2 (en) * 2008-02-27 2009-09-03 Radiomedix Inc. Radiolabeled hedgehog derivatives for imaging and therapy
US20100172889A1 (en) * 2008-12-05 2010-07-08 Catchmark Jeffrey M Degradable biomolecule compositions
WO2011047047A2 (en) * 2009-10-13 2011-04-21 The Penn State Research Foundation Composites containing polypeptides attached to polysaccharides and molecules
TW201542231A (zh) * 2011-06-06 2015-11-16 Kineta One Llc 以shk為主之醫藥組合物及其製備方法及用途
EP3024887B1 (en) 2013-07-26 2023-11-22 The Penn State Research Foundation Method for preparation of polymer compositions and coatings
US20180360973A1 (en) * 2015-12-02 2018-12-20 Hanmi Pharm. Co., Ltd. Protein conjugate using a fatty acid derivative and method for preparation thereof
CN113167782B (zh) * 2018-10-30 2025-07-11 私募蛋白质体操作有限公司 用于样品质量评估的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364839A (en) * 1990-06-18 1994-11-15 Genetics Institute, Inc. Osteoinductive pharmaceutical formulations
WO1992009697A1 (en) * 1990-11-30 1992-06-11 Celtrix Laboratories, Inc. USE OF A BONE MORPHOGENETIC PROTEIN IN SYNERGISTIC COMBINATION WITH TGF-β FOR BONE REPAIR
US5789543A (en) * 1993-12-30 1998-08-04 President And Fellows Of Harvard College Vertebrate embryonic pattern-inducing proteins and uses related thereto
NZ278765A (en) * 1993-12-30 1998-05-27 Harvard College Vertebrate proteins involved in spatial arrangements of differentiated tissues called hedgehog proteins, their production and use
US6281332B1 (en) * 1994-12-02 2001-08-28 The Johns Hopkins University School Of Medicine Hedgehog-derived polypeptides
US5700774A (en) * 1996-03-26 1997-12-23 Genetics Institute, Inc. Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide, and methods of inducing cartilage by administration of same
GB9614871D0 (en) 1996-07-15 1996-09-04 Smithkline Beecham Plc Compounds
EP0966478A4 (en) * 1996-10-07 2002-08-21 Univ Johns Hopkins Med Novel hedgehog-derived polypeptides
EP1034269A1 (en) * 1997-11-28 2000-09-13 Roche Diagnostics GmbH An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes
EA003739B1 (ru) * 1997-12-03 2003-08-28 Байоджен, Инк. Гидрофобно-модифицированные белки, способы их получения и их применение
US6897297B1 (en) * 1997-12-03 2005-05-24 Curis, Inc. Hydrophobically-modified protein compositions and methods
DE69928040T2 (de) * 1998-04-30 2006-07-27 Curis, Inc., Cambridge Aktives Hedgehog-Protein-Konjugat, Verfahren zur Herstellung und Verwendung
ES2253851T3 (es) * 1998-08-07 2006-06-01 Curis, Inc. Composicion farmaceutica estable de proteinas hedgehog y uso de la misma.
US7052514B2 (en) * 2000-04-28 2006-05-30 Curis, Inc. Methods and reagents for tissue engineering of cartilage in vitro

Also Published As

Publication number Publication date
NO992090D0 (no) 1999-04-29
US20070191274A1 (en) 2007-08-16
US7153836B2 (en) 2006-12-26
US6468978B1 (en) 2002-10-22
KR19990083621A (ko) 1999-11-25
JP2000053699A (ja) 2000-02-22
IL129620A0 (en) 2000-02-29
MA26625A1 (fr) 2004-12-20
NO992090L (no) 1999-11-01
CN1233616A (zh) 1999-11-03
HUP9901411A2 (hu) 1999-12-28
EP0953576A1 (en) 1999-11-03
US6818623B2 (en) 2004-11-16
AU2500999A (en) 1999-11-11
DE69928040T2 (de) 2006-07-27
AU719797B2 (en) 2000-05-18
IL129620A (en) 2009-06-15
EP1557427A3 (en) 2005-10-19
CY1105683T1 (el) 2010-12-22
NZ335385A (en) 2000-09-29
DE69928040D1 (de) 2005-12-08
US20030139574A1 (en) 2003-07-24
SG80028A1 (en) 2001-04-17
ATE308563T1 (de) 2005-11-15
HU9901411D0 (en) 1999-07-28
EP1557427A2 (en) 2005-07-27
ES2252886T3 (es) 2006-05-16
US20050148510A1 (en) 2005-07-07
CA2269221A1 (en) 1999-10-30
JP3433136B2 (ja) 2003-08-04
EP0953576B1 (en) 2005-11-02

Similar Documents

Publication Publication Date Title
NO992090D0 (no) Aktivt proteinkonjugat fra pinnsvin samt fremgangsmÕte for fremstilling og anvendelse derav
DE3774274D1 (de) Solubilisierung von proteinen fuer pharmazeutsche zusammensetzungen.
BR0012926A (pt) Polipeptìdeos quiméricos, método para a sua produção e seus usos
DE69807679D1 (de) Zusammensetzungen aus konjugaten des stabilen, aktiven, menschlichen ob proteins mit der fc kette von immunoglobulinen und damit zusammenhängende verfahren
SE8904239D0 (sv) A recombinat human factor viii derivative
FI973048A0 (fi) Menetelmät ja koostumukset hydrofiilisten molekyylien lipidisoimiseksi
SE9100799D0 (sv) Recombinant human factor viii derivatives
EA200000652A1 (ru) Кристаллы глюкагоноподобного пептида 1
CO4830493A1 (es) Anticuerpos contra cd40 humano
ES2067017T3 (es) Procedimiento para someter a preparacion un material de implantacion biologico.
EA200000601A1 (ru) Сайт - специфичное получение конъюгатов grf с полиэтиленгликолем
ATE254138T1 (de) An den erythropoietin-rezeptor bindende zusammensetzungen und peptide
GR3018691T3 (en) Amino acids, peptides or derivatives thereof coupled to fats
DE69736129D1 (de) Verfahren und Zusammensetzungen für die Behandlung von neoplastichen Krankheiten
ATE377026T1 (de) Behandlung von fettleibigkeit
ES2180948T3 (es) Peptido que proviene de una forma soluble de la acetilcolinesterasa, activo como modulador del canal.
MX9203175A (es) Composicion de implante que contiene un peptido, polipeptido o proteina biologicamente activa y procedimiento para su preparacion.
DK292584A (da) Biologisk aktive konjugater, deres fremstilling og anvendelse
BR9604843A (pt) Peptìdeo e derivado do mesmo, e, droga e composição para tratar osteopatia
TR199900933A2 (xx) Etkin, dikenli yapı proteni eşleniği.
SE9101586D0 (sv) Modified thioredoxin and its use
DK661888A (da) Biologisk aktive molekyler